Chao Yuan

Chao Yuan

Auto-generated profile, based on publicly available information

Chao Yuan

Department of Neurology, NanFang Hospital, Southern Medical University, Guangdong, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
QHQin Huang
Qin Huang
SSShuqun Shen
Shuqun Shen
HQHang Qu
Hang Qu
YHYu Huang
Yu Huang
DWDanni Wu
Danni Wu
CYChao Yuan
Chao Yuan
Background: Previous studies show that the high‐mobility group box protein 1 (HMGB1) and the toll‐like receptor 4 (TLR4) participate in systemic lupus erythematosus (SLE). The two molecules contribute to the occurrence and persistence of seizures in various disease conditions, such as epilepsy. Since seizures are one of the most severe complications associated with neuropsychiatric SLE (NPSLE), the current study aimed at investigating whether HMGB1 and TLR4 play any role in NPSLE related seizures. Methods: Data from 291 SLE patients and 100 healthy controls (HC) were prospectively collected from 2013 to 2018. The ELISA test was used to determine serum levels of HMGB1 for all patients and HC and cerebrospinal fluid (CSF) levels of NPSLE patients. The expression levels of TLR4 by the peripheral blood monocytes (PBMCs) were determined by real-time PCR of TLR4 mRNA. Binary logistic regression and ROC curve analysis were used to predict NPSLE. Results: Among the 291 SLE patients, 188 had active disease and were grouped into two, NPSLE (N=86) and Non-NPSLE (N=102) groups. Among the NPSLE patients, 21 had seizure disorders. Serum HMGB1 levels were increased in NPSLE (8.73±0.29 ng/mL) and were associated with disease activity (r=0.6527, P=0.000). Both serum and CSF HMGB1 levels in NPSLE patients with seizure disorders (9.59±0.63 and 2.90±2.29 ng/mL, respectively) were higher than in patients with other neuropsychiatric symptoms (8.45±0.33 and 2.56±1.70 ng/mL, respectively), though without significance. The gene expression of mRNA TLR4 in PBMCs was similar to serum HMGB1 in the investigated groups. Independent predictors of NPSLE were SLEDAI-2k (OR 1.25; 95% CI: 1.155–1.353), serum HMGB1 (OR 1.659; 95% CI: 1.266–2.175), and anti-Rib-P Ab (OR 3.296; 95% CI: 1.013–10.725). ROC curves for the above predictors had a large AUC (95% CI) of 0.936 (0.900–0.971), indicating a good prediction of NPSLE occurrence. Conclusions: The expression of HMGB1 and TLR4 was increased in NPSLE, but HMGB1 and TLR4 had minimal effect on NPSLE related seizures. The serum levels of HMGB1 were positively correlated with disease activity, and could, therefore, be a potential biomarker of NPSLE for use in future clinical practice.

1 January 2017 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
YYYan Yang
Yan Yang
CYChao Yuan
Chao Yuan
SSShu-Qun Shen
Shu-Qun Shen
XWXue-Er Wang
Xue-Er Wang
QMQing-Hua Mei
Qing-Hua Mei
HQHuang Qin
Huang Qin
Objective. Seizure disorders are one of the most disabling, life-threatening, and the least understood syndromes associated with neuropsychiatric SLE (NPSLE). N-Methyl-D-aspartate (NMDA) receptors are a subgroup of the glutamate receptor family, whose NR2A subunit was found on neuronal cells (anti-NR2A) in NPSLE patients with different types of epilepsy. The present study was conducted to determine the serum levels of anti-NR2A antibodies in a large group of SLE patients, to investigate the possible correlation between the presence of the NR2A specific antibodies and NPSLE-related seizure disorders.Methods and Results. The study population consisted of 107 SLE patients and 43 age- and sex-matched healthy controls. 73 SLE patients had active disease. 36 of these had NPSLE. NMDA levels were measured by ELISA. Clinical and serological parameters were assessed according to routine procedures. The levels of anti-NR2A antibodies were significantly higher in NPSLE patients, compared with non-NPSLE patients and healthy controls. Furthermore, the levels of NPSLE in patients with seizure disorders were shown to be higher than in those with cognitive dysfunction and other CNS symptoms, however, without significance. Increase in serum anti-NR2A antibodies levels correlated to anti-dsDNA antibody and SLEDAI as well as complement levels.Conclusion. We suggest that anti-NR2A antibodies play a role in the pathogenesis of NPSLE with seizure disorders.

31 July 2023 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
JZJiaman Zheng
Jiaman Zheng
JZJiayu Zhang
Jiayu Zhang
YJYing Jin
Ying Jin
YWYang Wang
Yang Wang
LXLiying Xu
Liying Xu
CYChao Yuan
Chao Yuan

28 September 2022 in Frigid Zone Medicine
Verified
Journal Article
Open access
PDF file
XXXun Xu
Xun Xu
CLChunyang Liu
Chunyang Liu
RLRui Liu
Rui Liu
QJQiuyi Jiang
Qiuyi Jiang
ELEnzhou Lu
Enzhou Lu
GYGuang Yang
Guang Yang
The purpose of this study was to find a suitable model to evaluate the relationship between temperature and intracerebral hemorrhage (ICH) and explore the effects of cold spells and heat waves on the clinicopathological parameters of ICH patients. We conducted a retrospective study based on the ICH admission in the First Affiliated Hospital of Harbin Medical University from 2015 to 2020 (N = 11 124). The relationship between different seasons and the number of patients with ICH was explored. Poisson Akaike information criterion (AIC) was used to select the optimal model for temperature and ICH. Binary logistic regression analysis was used to investigate the association between extreme temperatures and clinicopathological features. Hospital admissions for patients with ICH showed monthly changes. The optimal cold spell was defined as the daily average temperature < 3rd percentile, lasting for five days, while the optimal heat wave was defined as the daily average temperature >97th percentile, lasting for three days. Based on the generalized extreme weather model, cold climate significantly increased the risk of hematoma volume expansion (OR 1.003; 95% CI: 1.000–1.005, P = 0.047). In the optimal model, the occurrence of cold spells and heat waves increased the risk of midline shift in both conditions (OR 1.067; 95% CI: 1.021–1.115, P = 0.004; OR 1.077; 95% CI: 1.030–1.127, P = 0.001). Our study shows that seasonal cold spells and heat waves are essential factors affecting ICH severity, and targeted preventive measures should be taken to minimize the pathological impacts.

27 July 2023 in Frontiers in Neurology
Verified
Journal Article
Open access
DCDong-Hua Chen
Dong-Hua Chen
WLWei Li
Wei Li
HJHaishan Jiang
Haishan Jiang
CYChao Yuan
Chao Yuan
Introduction: Patients with mitochondrial disorders always show neurological deficits. However, the diversity of clinical manifestations, genetic heterogeneity and threshold effect caused by maternal heredity make its diagnosis very challenging.Case presentation: A 30-year-old female presented to our neurology department with a recurrence of symmetrical weakness proximally in the lower extremities. Seven years ago, the patient had a sudden onset of persistent weakness in bilateral proximal lower extremities, along with elevated creatinine kinase (CK) and CK-MB. Given the diagnosis of Guillain-Barre syndrome, she was treated with high-dose glucocorticoid (GC) therapy at the local hospital and recovered. After admission to our hospital, laboratory analysis revealed elevated CK and alpha-hydroxybutyrate dehydrogenase in serum. Electrocardiography showed sinus tachycardia and left high ventricular voltage. Electromyography (EMG) and evoked potential (EP) suggested peripheral neurogenic damage of the upper and lower extremities with myogenic wear. Chronic inflammatory demyelinating polyneuropathy (CIDP) was initially considered, but neurological symptoms were not significantly improved with glucocorticoid shock therapy. An elevated level of lactate was found. The short-tau inversion recovery (STIR) axial magnetic resonance image (MRI) revealed mild hyperintensities, indicating muscle edema. Meanwhile, muscle biopsies suggested pathological changes in mitochondrial disorders (MIDs) and neuronal damage. Further mitochondrial genome analysis revealed a heteroplasmic m3271 T>C mutation in the mitochondrial tRNA-Leu gene (UUR). Collectively, the patient was finally diagnosed with mitochondrial disorder and apparently improved after the corresponding treatment to regulate energy metabolism.Conclusions: To our knowledge, it's the first report about MELAS with 3271 mutation that have only shown peripheral nerve motion impairment. Proximal weakness is also common in CIDP. In the context of this patient's experience, mitochondrial genome analysis provides an auxiliary criterion for differential diagnosis between MIDs and CIDP. In the meantime, we discussed the clinical effect of GCs on MIDs.

1 December 2023 in Research Square
Verified
Preprint
Open access
PDF file
JZJiayu Zhang
Jiayu Zhang
YJYing Jin
Ying Jin
LXLiying Xu
Liying Xu
YWYang Wang
Yang Wang
JZJiaman Zheng
Jiaman Zheng
CYChao Yuan
Chao Yuan
Background and objectives The peripheral neuropathy system in Primary Sjogren's syndrome (pSS-PNS) is often disregarded as a significant neuropathy, and there is limited research on the underlying pathological mechanisms. This study aimed to explore some possible processes by proteomic analysis. Methods Samples of the sural nerve were collected from patients diagnosed with pSS-PNS (n=3) and chronic inflammatory demyelinating polyneuropathy (CIDP) (control, n=3). A data-independent acquisition (DIA) proteomic analysis was used to detect differentially expressed proteins (DEPs). Functional annotation of DEPs and gene modules was performed using Gene Ontology (GO), Gene Set Enrichment Analysis (GSEA), Protein-protein interaction (PPI) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. The targeted proteins were validated using the parallel reaction monitoring (PRM) method. Results Samples of the sural nerve were collected from pSS-PNS patients (n=3) and CIDP patients (n=3),and subjected to differential proteomic analysis (DIA). As a result, 187 proteins were found to be significantly regulated between pSS-PNS patients and the control group. 42 of these proteins were selected for quantification through parallel reaction monitoring (PRM), and five of them (F2, FGG, FN1, INA, FERMT3) displayed consistent expression patterns between DIA and PRM. Conclusion F2, FGG, FN1, INA, and FERMT3 exhibited differential expression in the sural nerves of patients with PNS secondary to Sjögren's syndrome (pSS-PNS). These genes have the potential to serve as diagnostic and therapeutic targets for pSS-PNS, and their pathogenesis may be linked to platelet activation.